Answer
They may interfere with durvalumab’s pharmacodynamic activity and efficacy; physiological systemic corticosteroid doses (≤10 mg/day prednisone or equivalent) are excepted, and systemic corticosteroids or other immunosuppressants may be used after starting durvalumab to treat immune-related adverse reactions.
Sources for this answer
- IMFINZI 50 mg/mL concentrate for solution for infusionAstraZeneca UK Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 38Document updated
Sources checked